Blood Pressure Medication Recall: What Is In This That May Cause Cancer?

The FDA announced that Sciegen Pharmaceuticals, Inc. is voluntarily recalling irbesartan tablets.

Source: Forbes.com Healthcare News - November 2, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news